| Literature DB >> 17386112 |
Giovanni Minardi1, Carla Manzara, Giovanni Pulignano, Giampaolo Luzi, Daniele Maselli, Giovanni Casali, Francesco Musumeci.
Abstract
BACKGROUND: Surgical "anatomical" repair is the most frequent technique used to correct mitral regurgitation due to severe myxomatous valve disease. Debate, however, persists on the efficacy of this technique, as well as on the durability of the repaired valve, and on its functioning and hemodynamics under stress conditions. Thus, a basal and Dobutamine echocardiographic (DSE) study was carried out to evaluate these parameters at mid-term follow-up. METHODS ANDEntities:
Mesh:
Substances:
Year: 2007 PMID: 17386112 PMCID: PMC1845153 DOI: 10.1186/1476-7120-5-17
Source DB: PubMed Journal: Cardiovasc Ultrasound ISSN: 1476-7120 Impact factor: 2.062
Pre-operative, one month and follow-up echocardiography (20 pts)
| LA size (mm) | 50 ± 8 | 46 ± 6 | 44 ± 6 | ns | |
| LVEDD (mm) | 61 ± 5 | 55 ± 6 | 52 ± 7 | 0.01 | |
| LVESD (mm) | 33 ± 6 | 35 ± 6 | 34 ± 9 | ns | |
| FS (%) | 44 ± 7 | 36 ± 6 | 35 ± 10 | 0.008 | |
| LVEDV (ml) | 127 ± 4 | 112 ± 33 | 114 ± 56 | ns | |
| LVESV (ml) | 55 ± 30 | 56 ± 21 | 57 ± 20 | ns | |
| EF (%) | 60 ± 10 | 50 ± 7 | 54 ± 12 | 0.038 | |
| MR grade | (3+;4+) | 11; 9 | 0;0 | ns | 0.001* |
| (0;1+;2+) | 0;0;0 | 11;8;1 | 11;8;1 | ns** | |
| sPAP (mmHg) | 42 ± 16 | 38 ± 14 | 30 ± 11 | ns | |
LA = left atrium; LVEDD = left ventricular end diastolic diameter; LVESD = left ventricular end systolic diameter; FS = fractional shortening; LVEDV = left ventricular end diastolic volume
LVESV = left ventricular end systolic volume; EF = ejection fraction
MR = mitral regurgitation; sPAP = systolic pulmonary artery pressure
* baseline vs one month
** one month vs follow-up
Baseline and dobutamine stress echocardiography (20 pts)
| Mitral valve area (cm2) | 2.9 ± 0.7 | 4.5 ± 2 | <0.001 |
| Mx PG (mmHg) | 7.2 ± 1.9 | 14 ± 3.7 | 0.4 |
| Md PG (mmHg) | 2.7 ± 1 | 6.3 ± 1.5 | <0.001 |
| Mitral Annulus, systole (mm) | 41 ± 3.4 | 38 ± 2.2 | <0.001 |
| Mitral Annulus, diastole (mm) | 43.7 ± 3.3 | 45.7 ± 3 | 0.4 |
| Mitral Annulus, area (cm2) | 3.4 ± 0.4 | 3.7 ± 0.6 | 0.1 |
| IAA | 1.9 ± 0.3 | 2.1 ± 0.3 | 0.1 |
| sPAP (mmHg) | 33.5 ± 10 | 41.6 ± 12 | 0.03 |
| MR grade (1+/2+) | 9/20 | 10/20 | ns |
| HR (beats/min) | 75 ± 19 | 133 ± 22 | <0.001 |
| SBP (mmHg) | 124 ± 14 | 127 ± 24 | 0.6 |
| DBP (mmHg) | 76 ± 9 | 70 ± 9 | 0.1 |
| CO (L/min) | 3.9 ± 1.9 | 6.6 ± 2.8 | <0.001 |
| EF (%) | 50 ± 11 | 52 ± 12 | 0.3 |
| LVEDV (ml) | 114 ± 58 | 103 ± 56 | 0.05 |
| LVESV (ml) | 61 ± 50 | 54 ± 48 | 0.04 |
| LVOTO (%) | 0 | 30 | <0.001 |
Mx PG: maximum pressure gradient; Md PG: mean pressure gradient; IAA: indexed annular area; sPAP: systolic pulmonary artery pressure; MR: mitral regurgitation; HR: heart rate; SBP: systolic blood pressure; DBP: diastolic blood pressure; CO: cardiac output; EF: ejection fraction; LVEDV: left ventricular end diastolic volume; LVESV: left ventricular end systolic volume; LVOTO: patients with left ventricular outflow tract obstruction.
Figure 1Rest and Dobutamine echocardiogram following mitral valve repair. Panel A: Top: Two-dimensional echo, apical 4-chamber view: normal coaptation of mitral leaflets; systolic anterior movement (SAM) is absent. Middle: M-Mode echo, mitral valve: normal coaptation of mitral leaflets. Bottom: Two-dimensional echo, PW Doppler in left outflow tract (LVOT):normal peak systolic velocity. Panel B: Top: Two-dimensional echo, apical 4-chamber view: SAM of anterior mitral leaflet is present. Middle: M-Mode echo, mitral valve; SAM is present. Bottom: Two-dimensional echo, PW Doppler in LVOT: elevated peak mid-systolic velocity corresponding to 46 mmHg outflow gradient.